BridgeBio Pharma (BBIO) Operating Margin (2019 - 2026)
BridgeBio Pharma (BBIO) operating margin from Sep 30, 2019 to Mar 31, 2026. The current BridgeBio Pharma (BBIO) operating margin is -54.47%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of BridgeBio Pharma (BBIO)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -104.25% | -60.99% |
| 2024 | -267.22% | -95.91% |
| 2023 | -6530.86% | +890.08% |
| 2022 | -659.63% | -20.24% |
| 2021 | -827.07% | -85.62% |
| 2020 | -5751.27% | +776.17% |
| 2019 | -656.41% | N/A |
Comparison BridgeBio Pharma (BBIO) operating margin with competitors
BridgeBio Pharma (BBIO) operating margin is -54.47%.